Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · October 17, 2023

Esketamine Nasal Spray vs Quetiapine for Treatment-Resistant Depression

The New England Journal of Medicine

 

Additional Info

The New England Journal of Medicine
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
N. Engl. J. Med 2023 Oct 05;389(14)1298-1309, A Reif, I Bitter, J Buyze, K Cebulla, R Frey, DJ Fu, T Ito, Y Kambarov, PM Llorca, AJ Oliveira-Maia, T Messer, S Mulhern-Haughey, B Rive, C von Holt, AH Young, Y Godinov

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading